February 14, 2023 — Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Hamamatsu Photonics K.K., a forerunner in whole slide imaging systems, announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

10th International Breast Density & Cancer Risk Assessment Workshop

February 10, 2023 — Risk model-based lung cancer screening strategies, which select individuals based on p

Acquisition supports GE HealthCare’s $3 billion Ultrasound business by adding AI-enabled image guidance to ultrasound device portfolios

February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement to acquire Caption Health, Inc., a privately owned artificial intelligence (AI) healthcare leader that creates clinical applications to aid in early disease detection, using AI to assist in c

February 9, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ultrafast (UF) MRI provides beneficial information that can be used in surgical planning, including determining the need to perform sentinel lymph node biopsy. 

February 9, 2023 — Onsite Women’s Health, a leading national provider of breast health services, announces partnership with Volpara Health to adopt Volpara Analytics, an artificial intelligence (AI) software tool that improves mammography quality by assessing every mammogram image for appropriate positioning, compression and radiation dose.

February 9, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the presentation of additional results from its completed Phase 3 LIGHTHOUSE trial of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer, at the upcoming ASCO GU 2023 Genitourinary Cancers Symposium (ASCO GU).

February 8, 2023 — Carestream Health is partnering with Robarts Research Institute to increase and demonstrate the clinical value of digital X-ray, digital tomosynthesis and dual energy technologies to help improve the outcomes of patients with cardiothoracic and pulmonary diseases.

February 8, 2023 — New data published in the Journal of Clinical Oncology further quantify the vast lingering impact of the global COVID-19 pandemic on timely cancer screening, highlighting the urgent need for health care providers to address significant delays to cancer screenings in populations most likely to delay testing. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now